FDA Adverse Event Malfunction Summary report: N

INCEPTA

MDR report key: 3904888 · Received July 1, 2014

Report

Report Number
2124215-2014-10193
Event Type
Malfunction
Date Received
July 1, 2014
Date of Event
April 21, 2014
Report Date
April 21, 2014
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWP
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT RECENTLY THIS PATIENT EXPERIENCED INAPPROPRIATE SHOCK AS WELL AS INAPPROPRIATE ANTI-TACHYCARDIA PACING (ATP) WHICH LEAD TO THERAPY EXHAUSTION. THE PROGRAMMING WAS CHANGED IN AN EFFORT TO ALLEVIATE THIS FROM HAPPENING IN THE FUTURE. TO DATE, NO ADVERSE PATIENT EFFECTS HAVE BEEN REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
385396 INCEPTA IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWP GUIDANT CRM CLONMEL IRELAND E162

Patients

Seq Age Sex Outcome Treatment
1 54 YR 4087| 0293| E162